189.272 articles found

The Parkinson's Disease Drug Tolcapone and Analogues are Potent Glycomimetic Lectin Inhibitors of Pseudomonas aeruginosa LecA.

Leusmann S, Siebs E, Kuhaudomlarp S, Varrot A, Imberty A, Kuhn B, Lerner C, Grether U, Titz A.

Angew Chem Int Ed Engl · 2025-11-02

DOI: 10.1002/anie.202508864PMID: 41178200

Cannabis sativa extracts reduce inclusion formation in a cell model of alpha-synuclein aggregation.

de Almeida Cruz T, de Paulo Osorio R, de Menezes Epifanio NM, Merghani M, Pereira MD, de Almeida Chaves DS, Outeiro TF, Riger CJ.

Fitoterapia · 2025-11-02

DOI: 10.1016/j.fitote.2025.106968PMID: 41187864

Ocular motor dysfunction in patients with multiple system atrophy and Parkinson's disease.

Ling X, Ma X, Wan Z, Sun Y, Li F, Wei L, Li K, Chen J, Zhao G, Kim JS, Yang X, Wang Z.

Clin Neurophysiol · 2025-11-02

DOI: 10.1016/j.clinph.2025.2111413PMID: 41207204

Biallelic RFC1 Expansions Are a Rare Cause of Early-Onset and Familial Parkinson's Disease.

Kovanda A, Šušmelj L, Jaklič H, Lukežič T, Maver A, Petrovic I, Miskovic ND, Svetel M, Rački V, Vuletič V, Novakovic I, Peterlin B.

Clin Genet · 2025-11-02

DOI: 10.1111/cge.70095PMID: 41177915

α-Synuclein targeted therapy with multiple pathological improvement for Parkinson's disease by macrocyclic amphiphile nanomedicine

Gao JM, Li WB, Yi Y, Wei JJ, Gong MX, Pan BB, Su XC, Pan YC, Guo DS, Gong QH.

Biomaterials · 2025-11-01

Impedance-based dopamine detection neural probe utilizing dopamine antibody: Real-time quantification of dopamine

Park D, Ahn D, Choi J, Kim J, Song M, Wang P, Piao H, Park S, Jo EA, Kim HY, Choi HJ.

Biosensors and Bioelectronics · 2025-11-01

Abstract 372: Rapidly Progressive and Reversible Parkinsonism Secondary to Bilateral Subdural Hematomas

Levinson K.

Stroke (Hoboken, N.J.) · 2025-11-01

Erratum: [Erratum] Tofacitinib Improves Motor Symptoms in Parkinsonism Associated with a Heterozygous NGLY1 Variant and Autoimmune Disease.

Reina-Llompart N, Serrano-López S, Torres-Iglesias G, Álvarez-Troncoso J.

Eur J Case Rep Intern Med · 2025-11-01

DOI: 10.12890/2023_005975PMID: 41229653

A <i>meta</i>-analysis of the long-term efficacy of Amantadine for Levodopa-induced dyskinesia in Parkinson's disease.

Williams K, Curtis MA, Gombinsky L, Parmar P.

Clin Park Relat Disord · 2025-11-01

DOI: 10.1016/j.prdoa.2025.100405PMID: 41281192

Characteristics of pain symptoms in Parkinson's disease.

Hoang DT, Xing F, Truong D.

Clin Park Relat Disord · 2025-11-01

DOI: 10.1016/j.prdoa.2025.100404PMID: 41334475

Low β predicts motor output and cell degeneration in the A53T Parkinson's disease rat model.

Hofman K, Chen J, Sil T, Pellegrini F, Haufe S, Pozzi N, Palmisano C, Isaias IU, Koprich JB, Brotchie JM, Kühn AA, Matthies C, Reich MM, Muthuraman M, Volkmann J, Ip CW.

Brain · 2025-11-01

DOI: 10.1093/brain/awaf063PMID: 39965098

Noise Propagation and MP-PCA Image Denoising for High-Resolution Quantitative $R_2^{\rm{*}}$, $T_2^{\rm{*}}$, and Magnetic Susceptibility Mapping (QSM).

Doniza L, Lee M, Blumenfeld-Katzir T, Artzi M, Ben-Bashat D, Aizenstein O, Radunsky D, Kirkham F, Thomas G, Weil RS, Shmueli K, Ben-Eliezer N.

IEEE Trans Biomed Eng · 2025-11-01

DOI: 10.1109/tbme.2025.3566561PMID: 40315096